Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of High-Flow Nasal Oxygen Therapy on Respiratory Complications and Post-Procedural Recovery Time in Patients Undergoing Sedated EBUS-TBNA

NCT07760727 is registered in ClinicalTrials.gov with Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital as lead sponsor.

NCT NCT07760727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07760727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of High-Flow Nasal Oxygen Therapy on Respiratory Complications and Post-Procedural Recovery Time in Patients Undergoing Sedated EBUS-TBNA
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
August 20, 2026
Completion date
November 20, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood gas analysis, endobronchial ultrasound - transbronchial needle aspiration, high flow oxygen therapy, sedation, sedation complication